论文部分内容阅读
幽门螺杆菌这个词已经为越来越多的人所认识。1983年,澳大利亚学者首次从胃上皮细胞分离出幽门螺杆菌(英文缩写Hp)。现已公认,幽门螺杆菌是慢性胃炎和消化性溃疡的重要病因之一。1994年,世界卫生组织国际癌症研究中心将其列为一级致癌因子。据披露,当今世界上约有一半以上的人被幽门螺杆菌所感染,而在发展中国家人群中,幽门螺杆菌感染率则更高。同时,好长时间以来,许多慢性炎和消化性溃疡等胃部疾病在治疗中,缺乏检测幽门螺杆菌感染的意识,而又滥用抗生素,特别是一些基层诊疗机构动不动就开各种抗生素,造成患者疾病迁延不愈,反复发作,耽误了及时的规范治疗。为帮助患者,特别是中老年患者规范治疗慢性胃炎和消化性溃疡等胃部疾病,本刊特约请王崇文教授撰写了《慢性胃炎的抗幽门螺杆菌治疗与滥用抗生素》一文。王教授特别强调:慢性胃炎的抗幽门螺杆菌治疗与滥用抗生素,是当前一个十分突出的问题,必须引起高度注意!
The term Helicobacter pylori has been recognized by more and more people. In 1983, Australian scholars first isolated Helicobacter pylori (Hp) from gastric epithelial cells. It is now recognized that Helicobacter pylori is one of the important causes of chronic gastritis and peptic ulcer. In 1994, the World Health Organization International Agency for Research on Cancer classified it as a carcinogen. According to the disclosure, about half of the people in the world are infected with Helicobacter pylori, while Helicobacter pylori infection rate is even higher among the population in developing countries. At the same time, for a long time, many chronic diseases such as chronic inflammation and peptic ulcer diseases are lack of awareness of detecting Helicobacter pylori infection while abusing antibiotics. In particular, some grass-roots diagnosis and treatment institutions often open various kinds of antibiotics to cause Prolonged unhealed patients with diseases, recurrent, delayed timely standardized treatment. In order to help patients, especially in the elderly to standardize the treatment of chronic gastritis and peptic ulcer diseases such as stomach, this article specifically invited Professor Wang Chongwen authored “Chronic gastritis anti-Helicobacter pylori treatment and abuse of antibiotics,” a article. Professor Wang stressed: chronic gastritis anti-Helicobacter pylori treatment and abuse of antibiotics, is a very prominent issue, we must pay great attention!